Download PDF
1 / Pages

Other users also viewed these articles

Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH) E. Díaz; R. Amézaga Menéndez; P. Vidal Cortés; M.G. Escapa; B. Suberviola; A. Serrano Lázaro; P. Marcos Neira; M. Quintana Díaz; M. Catalán González;
Med Intensiva. 2021;45:104-21
Severe infection due to the SARS-CoV-2 coronavirus: Experience of a tertiary hospital with COVID-19 patients during the 2020 pandemic A. Rodríguez; G. Moreno; J. Gómez; R. Carbonell; E. Picó-Plana; C. Benavent Bofill; R. Sánchez Parrilla; S. Trefler; E. Esteve Pitarch; L. Canadell; X. Teixido; L. Claverias; M. Bodí;
Med Intensiva. 2020;44:525-33
A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patients G. Moreno; M. Ruiz-Botella; I. Martín-Loeches; J. Gómez Álvarez; M. Jiménez Herrera; M. Bodí; F. Armestar; A. Marques Parra; Á. Estella; S. Trefler; R. Jorge García; J. Murcia Paya; P. Vidal Cortes; E. Díaz; R. Ferrer; A. Albaya-Moreno; L. Socias-Crespi; J.M. Bonell Goytisolo; S. Sancho Chinesta; A. Loza; L. Forcelledo Espina; J.C. Pozo Laderas; M. deAlba-Aparicio; L. Sánchez Montori; I. Vallverdú Perapoch; V. Hidalgo; V. Fraile Gutiérrez; A.M. Casamitjana Ortega; F. Martín Serrano; M. Nieto; M. Blasco Cortes; J. Marín-Corral; J. Solé-Violán; A. Rodríguez;
Med Intensiva. 2023;47:23-33